LESLIE SCARROTT: Open Payments
NPI 1578093282 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 13 payments from 8 companies in 2025. Trend: 2023 $174 · 2024 $150 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| PFIZER INC. | 2 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: CAPLYTA, PREVNAR 20, JOURNAVX, NEXLETOL, REXULTI, MOUNJARO, GARDASIL 9, Ozempic.
Industry payments across CA — which companies pay providers there.
